Sign in Subscribe
Cancer

Robotic Surgery Shows Promise in Treating Advanced Gastric Cancer

Strategic Insights

— 2 min read

A new study published in the Journal of Engineering has found that robotic surgery after neoadjuvant therapy may be a treatment approach with great potential for development and may be used as a new treatment method for locally advanced gastric cancer. The study, conducted by researchers at the People's Hospital of Xinjiang Uygur Autonomous Region, aimed to evaluate the efficacy, safety, and advantages of robotic gastrectomy for gastric cancer after neoadjuvant therapy, comparing it with traditional laparoscopic gastrectomy.

Key Takeaways:

  • The study included four non-randomized controlled trials from East Asia involving neoadjuvant therapy for advanced gastric cancer with robotic gastrectomy and laparoscopic gastrectomy interventions.
  • Robotic surgery significantly extended operative time, with a mean difference of 82.16 minutes (95% CI: 65.39 to 98.94, P < 0.001) compared to laparoscopic surgery.
  • Robotic surgery resulted in fewer postoperative complications, with a significant difference in the rate of serious complications (OR: 0.35, 95% CI: 0.21 to 0.59, P < 0.001).
  • The study found that robotic surgery had several advantages over laparoscopic surgery, including shorter hospital stays and fewer re-admissions within 30 days after surgery.
  • The research concluded that robotic surgery after neoadjuvant therapy may be a treatment approach with great potential for development and may be used as a new treatment method for locally advanced gastric cancer.
  • 569 participants were included in the analysis.
  • The study was based on a systematic review and meta-analysis of existing studies.
  • The research was conducted by researchers at the People's Hospital of Xinjiang Uygur Autonomous Region.
  • The study was published in the Journal of Engineering.
  • The full study includes a detailed analysis of the outcomes of robotic surgery after neoadjuvant therapy.

Statistics:

  • 82.16 minutes: the mean difference in operative time between robotic and laparoscopic surgery.
  • 65.39 to 98.94: the 95% confidence interval for the mean difference in operative time.
  • 0.35: the odds ratio for the rate of serious complications with robotic surgery compared to laparoscopic surgery.
  • 21 to 59: the 95% confidence interval for the odds ratio.
  • P < 0.001: the significance level for the difference in operative time and serious complications.
  • 30 days: the time period for re-admission after surgery.

Sources:

  • Short-term outcomes of robotic vs. laparoscopic surgery for gastric cancer after neoadjuvant therapy: a systematic review and meta-analysis. BMC Cancer, 2025;25(1):1002.
  • People's Hospital of Xinjiang Uygur Autonomous Region Reports Findings in Gastric Cancer (Short-term outcomes of robotic vs. laparoscopic surgery for gastric cancer after neoadjuvant therapy: a systematic review and meta-analysis). Journal of Engineering. June 16, 2025; p 2182.
  • BioMed Central. www.biomedcentral.com/
  • BMC Cancer. www.biomedcentral.com/bmccancer/
  • NewsRx. People's Hospital of Xinjiang Uygur Autonomous Region Reports Findings in Gastric Cancer (Short-term outcomes of robotic vs. laparoscopic surgery for gastric cancer after neoadjuvant therapy: a systematic review and meta-analysis). Journal of Engineering. June 16, 2025; p 2182.

Read more